Korean Pharmbio Selected as 'Strong Small Business' by Ministry of Employment and Labor

[Asia Economy Reporter Lee Gwan-joo] Korea Pharmbio announced on the 24th that it has been selected as a '2022 Small Giant Company' by the Ministry of Employment and Labor.

The Ministry of Employment and Labor has been selecting and announcing Small Giant Companies since 2012 to provide information on excellent small and medium-sized enterprises (SMEs) and improve public awareness. The selection criteria include high employment retention rates, high credit rating grades, no wage arrears, and no industrial accident deaths within the past three years. Selected companies receive various preferential benefits such as corporate promotion and selection for government support programs.

Korea Pharmbio is a pharmaceutical company specializing in the manufacturing and import/export of pharmaceuticals, focusing on the development of various specialized medicines in cooperation with excellent foreign pharmaceutical companies in the United States, Japan, the United Kingdom, and the European Union.

Nam Bong-gil, Chairman of Korea Pharmbio, said, “Being selected as a Small Giant Company this time is the result of considering not only the external growth of the company but also its internal growth.” He added, “We will continue to think and strive to ensure that Korea Pharmbio employees can work with satisfaction in a better environment.”

This content was produced with the assistance of AI translation services.